River & Mercantile Asset Management LLP Acquires New Stake in Endo International PLC (ENDP)
River & Mercantile Asset Management LLP acquired a new position in Endo International PLC (NASDAQ:ENDP) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 165,750 shares of the company’s stock, valued at approximately $1,851,000. River & Mercantile Asset Management LLP owned approximately 0.07% of Endo International PLC at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of the company. James Investment Research Inc. purchased a new stake in Endo International PLC during the second quarter worth $113,000. Macquarie Group Ltd. raised its stake in Endo International PLC by 132.1% in the fourth quarter. Macquarie Group Ltd. now owns 6,500 shares of the company’s stock worth $107,000 after buying an additional 3,700 shares during the period. OppenheimerFunds Inc. raised its stake in Endo International PLC by 182.9% in the first quarter. OppenheimerFunds Inc. now owns 2,873,153 shares of the company’s stock worth $32,065,000 after buying an additional 1,857,678 shares during the period. Hartford Investment Management Co. purchased a new stake in Endo International PLC during the first quarter worth $1,363,000. Finally, Russell Investments Group Ltd. raised its stake in Endo International PLC by 20.9% in the second quarter. Russell Investments Group Ltd. now owns 325,860 shares of the company’s stock worth $3,640,000 after buying an additional 56,407 shares during the period. 90.74% of the stock is currently owned by institutional investors.
Endo International PLC (NASDAQ ENDP) opened at 9.00 on Tuesday. Endo International PLC has a 1-year low of $7.41 and a 1-year high of $23.98. The company’s market capitalization is $2.01 billion. The stock’s 50 day moving average is $10.12 and its 200-day moving average is $11.29.
Endo International PLC (NASDAQ:ENDP) last posted its quarterly earnings data on Tuesday, August 8th. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.74 by $0.19. The company had revenue of $875.73 million for the quarter, compared to analyst estimates of $832.66 million. Endo International PLC had a negative net margin of 126.93% and a positive return on equity of 37.58%. The business’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.86 earnings per share. On average, analysts expect that Endo International PLC will post $3.52 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “River & Mercantile Asset Management LLP Acquires New Stake in Endo International PLC (ENDP)” was first published by Watch List News and is owned by of Watch List News. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/river-mercantile-asset-management-llp-acquires-new-stake-in-endo-international-plc-endp/1529602.html.
A number of analysts recently weighed in on ENDP shares. Oppenheimer Holdings, Inc. reissued a “hold” rating on shares of Endo International PLC in a research report on Sunday, July 23rd. Vetr raised shares of Endo International PLC from a “strong sell” rating to a “sell” rating and set a $11.34 price objective on the stock in a research report on Wednesday, May 17th. William Blair reissued a “market perform” rating on shares of Endo International PLC in a research report on Wednesday, June 14th. Zacks Investment Research lowered shares of Endo International PLC from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Finally, Canaccord Genuity set a $14.00 price objective on shares of Endo International PLC and gave the stock a “hold” rating in a research report on Monday, May 22nd. Three analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and five have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $14.75.
In other news, CEO Paul Campanelli acquired 6,500 shares of the company’s stock in a transaction dated Monday, August 14th. The shares were bought at an average price of $7.71 per share, for a total transaction of $50,115.00. Following the completion of the purchase, the chief executive officer now directly owns 213,620 shares of the company’s stock, valued at approximately $1,647,010.20. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Terrance J. Coughlin acquired 20,000 shares of the company’s stock in a transaction dated Thursday, August 10th. The shares were purchased at an average price of $7.70 per share, for a total transaction of $154,000.00. Following the purchase, the chief operating officer now directly owns 181,369 shares of the company’s stock, valued at $1,396,541.30. The disclosure for this purchase can be found here. Insiders have bought 36,000 shares of company stock worth $279,460 in the last quarter. Insiders own 0.50% of the company’s stock.
Endo International PLC Company Profile
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.
Want to see what other hedge funds are holding ENDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Endo International PLC (NASDAQ:ENDP).
Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.